- Home
- JACK vs RIGL Comparison
JACK vs RIGL Comparison
Compare JACK & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JACK
- RIGL
- Stock Information
- Founded
- JACK 1951
- RIGL 1996
- Country
- JACK United States
- RIGL United States
- Employees
- JACK N/A
- RIGL N/A
- Industry
- JACK Restaurants
- RIGL Biotechnology: Pharmaceutical Preparations
- Sector
- JACK Consumer Discretionary
- RIGL Health Care
- Exchange
- JACK Nasdaq
- RIGL Nasdaq
- Market Cap
- JACK 364.4M
- RIGL 335.5M
- IPO Year
- JACK 1987
- RIGL 2000
- Fundamental
- Price
- JACK $18.85
- RIGL $35.11
- Analyst Decision
- JACK Hold
- RIGL Buy
- Analyst Count
- JACK 18
- RIGL 5
- Target Price
- JACK $34.06
- RIGL $38.20
- AVG Volume (30 Days)
- JACK 1.4M
- RIGL 689.6K
- Earning Date
- JACK 08-06-2025
- RIGL 11-06-2025
- Dividend Yield
- JACK 4.66%
- RIGL N/A
- EPS Growth
- JACK N/A
- RIGL N/A
- EPS
- JACK N/A
- RIGL 5.43
- Revenue
- JACK $1,488,411,000.00
- RIGL $267,921,000.00
- Revenue This Year
- JACK N/A
- RIGL $59.93
- Revenue Next Year
- JACK N/A
- RIGL N/A
- P/E Ratio
- JACK N/A
- RIGL $6.46
- Revenue Growth
- JACK N/A
- RIGL 105.62
- 52 Week Low
- JACK $16.53
- RIGL $13.37
- 52 Week High
- JACK $54.42
- RIGL $43.72
- Technical
- Relative Strength Index (RSI)
- JACK 48.19
- RIGL 47.09
- Support Level
- JACK $17.43
- RIGL $35.56
- Resistance Level
- JACK $20.04
- RIGL $38.72
- Average True Range (ATR)
- JACK 1.22
- RIGL 2.14
- MACD
- JACK 0.04
- RIGL -1.15
- Stochastic Oscillator
- JACK 37.97
- RIGL 13.63
About JACK Jack In The Box Inc.
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America under the Jack in the Box and Del Taco brands. The company's menu offers burgers, tacos, regular and curly fries, specialty sandwiches, salads, and ice cream shakes. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.